We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.COLLABORATIVE RESEARCH AGREEMENT BETWEENCollaborative Research Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020THIS COLLABORATIVE RESEARCH AGREEMENT (hereinafter “Agreement”) is entered into by and between Pfizer Inc., a Delaware corporation having an office at 235 East 42nd Street, New York, New York 10017 (“Pfizer”); and Academic Medical Center, a [TYPE OF INSTITUTION] having an office at [INSERT ADDRESS] (hereinafter “AMC”) for the conduct of collaborative preclinical and clinical research studies in the area of identification and testing of new disease indications for existing Pfizer drug candidates.
COLLABORATIVE RESEARCH AGREEMENT BETWEENCollaborative Research Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020THIS COLLABORATIVE RESEARCH AGREEMENT (hereinafter “Agreement”) is entered into by and between Pfizer Inc., a Delaware corporation having an office at 235 East 42nd Street, New York, New York 10017 (“Pfizer”); and Academic Medical Center, a [TYPE OF INSTITUTION] having an office at [INSERT ADDRESS] (hereinafter “AMC”) for the conduct of collaborative preclinical and clinical research studies in the area of identification and testing of new disease indications for existing Pfizer drug candidates.
COLLABORATIVE RESEARCH AGREEMENT BETWEENCollaborative Research Agreement • June 25th, 2018
Contract Type FiledJune 25th, 2018THIS COLLABORATIVE RESEARCH AGREEMENT (hereinafter “Agreement”) is entered into by and between Pfizer Inc., a Delaware corporation having an office at 235 East 42nd Street, New York, New York 10017 (“Pfizer”); and Academic Medical Center, a [TYPE OF INSTITUTION] having an office at [INSERT ADDRESS] (hereinafter “AMC”) for the conduct of collaborative preclinical and clinical research studies in the area of identification and testing of new disease indications for existing Pfizer drug candidates.